ZYME
Zymeworks Inc.
PDUFA
Confirmed
zanidatamab
HER2-positive unresectable locally advanced or metastatic gastroesophageal adenocarcinoma (GEA)
Today
Aug 25, 2026
SEC 8-K
verified 2mo ago
Countdown card β